Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of C-type natriuretic peptide variants to treat skeletal dysplasia

Use of C-type natriuretic peptide variants to treat skeletal dysplasia

US Patent 12076372 · Granted Sep 3, 2024

Estimated economic value: $110,987,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2024
Adeno-associated virus Factor VIII vectors, associated viral particles and thera2023
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023
Use of C-type natriuretic peptide variants to treat skeletal dysplasia2023